Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR - Wikidata - wikimedia - TriplyDB

Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR

Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR

http://www.wikidata.org/entity/Q28477900

about

Analysis of the small RNA transcriptional response in multidrug-resistant Staphylococcus aureus after antimicrobial exposure Mechanisms of drug resistance: daptomycin resistance Mechanisms of vancomycin resistance in Staphylococcus aureus Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections Structure, Bioactivity, and Resistance Mechanism of Streptomonomicin, an Unusual Lasso Peptide from an Understudied Halophilic Actinomycete Within-host evolution of bacterial pathogens.Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus Validation of high throughput sequencing and microbial forensics applications.The pharmaco -, population and evolutionary dynamics of multi-drug therapy: experiments with S. aureus and E. coli and computer simulations Targeting of PBP1 by β-lactams determines recA/SOS response activation in heterogeneous MRSA clinical strains Inferring evolutionary histories of pathway regulation from transcriptional profiling data Beginner's guide to comparative bacterial genome analysis using next-generation sequence data.Intermediate-type vancomycin resistance (VISA) in genetically-distinct Staphylococcus aureus isolates is linked to specific, reversible metabolic alterations.Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.Modulation of cell wall synthesis and susceptibility to vancomycin by the two-component system AirSR in Staphylococcus aureus NCTC8325.Activated ClpP kills persisters and eradicates a chronic biofilm infection Dissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association.Construction and verification of the transcriptional regulatory response network of Streptococcus mutans upon treatment with the biofilm inhibitor carolacton High-throughput sequencing for the study of bacterial pathogen biology Improving indel detection specificity of the Ion Torrent PGM benchtop sequencer Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism.The evolutionary history of amino acid variations mediating increased resistance of S. aureus identifies reversion mutations in metabolic regulators Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibility Additional routes to Staphylococcus aureus daptomycin resistance as revealed by comparative genome sequencing, transcriptional profiling, and phenotypic studies.Reductive evolution and the loss of PDC/PAS domains from the genus Staphylococcus.Hyperexpression of α-hemolysin explains enhanced virulence of sequence type 93 community-associated methicillin-resistant Staphylococcus aureus.Mechanism of reduced vancomycin susceptibility conferred by walK mutation in community-acquired methicillin-resistant Staphylococcus aureus strain MW2 Convergent adaptation in the dominant global hospital clone ST239 of methicillin-resistant Staphylococcus aureus.WalK, the Path towards New Antibacterials with Low Potential for Resistance Development Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance.The Eukaryotic-Like Ser/Thr Kinase PrkC Regulates the Essential WalRK Two-Component System in Bacillus subtilis The Essential WalK Histidine Kinase and WalR Regulator Differentially Mediate Autolysis of Staphylococcus aureus RN4220 Transcriptional Analysis and Subcellular Protein Localization Reveal Specific Features of the Essential WalKR System in Staphylococcus aureus.Genomic Signatures of Experimental Adaptation to Antimicrobial Peptides in Staphylococcus aureus The posttranslocational chaperone lipoprotein PrsA is involved in both glycopeptide and oxacillin resistance in Staphylococcus aureus.The SAV1322 gene from Staphylococcus aureus: genomic and proteomic approaches to identification and characterization of gene function Impact of daptomycin resistance on Staphylococcus aureus virulence.The WalKR system controls major staphylococcal virulence genes and is involved in triggering the host inflammatory response β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.

P2860

Q24596120-72FA4092-A119-45F8-A0C8-07D6A87EDC35 Q26779944-45D9F147-AFF7-4CA7-885F-8C92B48B504E Q26829312-FB5CA620-9974-4DDD-9461-65D0802242B5 Q27011138-D7D35F26-F880-4588-80F5-4B3D71313F84 Q27644318-A57A5F41-1D0B-4CAC-8F6A-4C0F52A82DF6 Q28072013-C6FD9DF3-CDBA-4882-9CEB-0994D58E4033 Q28078930-FED34014-6F83-410A-9D6E-CE123B18D675 Q28391825-D97F96F0-659E-478F-88C2-3B30388FFF5D Q28485988-FF2460EB-2995-475E-B927-C58D066A9111 Q28486717-7B85702C-FC52-46C3-9F74-D16B9ABAC65D Q28675309-B2D6A409-E868-42C2-8766-F2C40AAFF9C0 Q30614820-F0507B3A-8BB6-42BD-86E2-73139C8D3DB4 Q33591402-1B5768EF-EEF3-4BD9-ABCA-F9183952031A Q33622927-CEBE84F8-6692-48A0-88F7-40788C7FCEB3 Q33644173-FF6C7BAF-E183-4F85-B3F3-EC2D7E0A7E53 Q33653007-6A5E8EE7-F674-4EF2-9A9F-4EECFC8AE2D2 Q33696380-7FDBC0C1-32AA-4B05-A99A-0F5E65E07E28 Q33722354-F4326C46-018F-4219-84BF-B08C52E1B555 Q34114326-5A0093B3-919A-4795-A9F2-B1D1E198D0D7 Q34430087-83AA67F1-14A0-4B9E-9ADB-C4ED78EB3BE3 Q34482589-49CF0F8B-6672-40BB-A38B-2201DD1357F8 Q34592835-67C36094-9293-4B11-A4F9-5CE122CDEF42 Q34632683-5570A605-4443-43A7-8C58-7E0E6787EDED Q34648042-C92E30B3-F208-4E88-8DF4-9C5DD8C6B0AD Q34883534-2E41F997-9A07-469B-B61D-617F27BB9882 Q35089836-C4BD26D2-DAD6-4B49-AF53-E8A0D7D05119 Q35105880-83C606E7-ECD7-427E-9CF4-8197C78BB319 Q35172374-98B889D9-A6E5-4D94-A1AB-E8D7542F32BF Q35181921-F3912B86-2518-4F09-916C-EF06541C0C0E Q35385568-18DF0EEB-C18D-48D0-9606-A79076CC6FBA Q35432770-9E148D96-69D2-4374-86D5-F10C16895AE7 Q35671883-FEF685E0-935A-4650-B7EA-0313BA567206 Q35687956-ACB82084-F799-47A1-A8D7-43B974E6A074 Q35965021-3590CDBC-EBD1-48AC-A63D-AFD48EEA45BA Q36016011-182780AB-DD67-4079-9DE9-AC82E9F49177 Q36086420-CBAC557F-7D70-49BB-BEA8-D3DF022758E4 Q36124237-BE5DE56B-DFA5-415E-A0C2-550619610C4C Q36147127-DA7333B7-54C4-4DE6-A4C7-9237BBA2726C Q36277416-02A2FDD8-460D-47B9-BEDC-9320D113C1B5 Q36396117-2AB0E4D0-95F9-4D15-89F5-7CD216EFF80E

P2860

Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR

http://www.wikidata.org/entity/Q28477900

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Evolution of multidrug resista ...... two component regulator WalKR

@ast

Evolution of multidrug resista ...... two component regulator WalKR

@en

Evolution of multidrug resista ...... two component regulator WalKR

@nl

type

label

Evolution of multidrug resista ...... two component regulator WalKR

@ast

Evolution of multidrug resista ...... two component regulator WalKR

@en

Evolution of multidrug resista ...... two component regulator WalKR

@nl

prefLabel

Evolution of multidrug resista ...... two component regulator WalKR

@ast

Evolution of multidrug resista ...... two component regulator WalKR

@en

Evolution of multidrug resista ...... two component regulator WalKR

@nl

P1433

Q28477900-7A875B56-F448-4531-AB59-B5313BECECB4

P1476

Q28477900-E8FBD025-8AA2-4CE9-8875-E8A64F5BAF0A

P2093

Q28477900-090852EA-FDA8-4E62-B585-1C761009B312

Q28477900-0AA35F8B-09D2-45CB-8904-1D5606926866

Q28477900-2179F275-FC89-4D03-A168-7A2E52666B6B

Q28477900-4FD26C23-8DC9-4C7A-A01E-A83D3050C830

Q28477900-5A1163FD-35E9-43C4-8133-585FC32B805D

Q28477900-7FEFABBD-3465-49CE-8EE7-D71DB2D50F8E

Q28477900-A966E48C-5A40-44DA-939B-6417ABD9BAEB

Q28477900-B23AA421-CB50-4935-A5E0-EBFF051DD840

Q28477900-E1DB67ED-8CE1-42A4-860E-2A1D5F20843A

P2860

Q28477900-0C09A556-959C-4026-A183-E16C4500773C

Q28477900-0C2F7067-3270-4BEC-8385-354E57386552

Q28477900-0F32D0BF-8B37-4145-9A88-B803334153FA

Q28477900-0FE05C70-046F-4AD5-9CB5-FB7BFBE46500

Q28477900-195051C1-6040-480B-9059-A10964FA70A9

Q28477900-1A0AEE7E-2B7E-444D-A695-291B6CB8111A

Q28477900-1FC52474-35C8-4AC3-9F3B-92BB049DC064

Q28477900-25FCDE83-9E79-41A8-AF37-7ECCC890668A

Q28477900-26A5C469-31D8-4C14-93B1-5B6B5C2E447B

Q28477900-2C07BCD8-04B8-423A-9F01-549FD6592C88

P304

Q28477900-D4DD8904-8F13-41CA-938F-55B8993825D2

P31

Q28477900-F19AD83B-C84C-4E2D-A7BA-198FE1933A5B

P3181

Q28477900-BD44417A-8223-4837-A70F-2B5825B11A01

P356

Q28477900-E7C09FEE-4AE2-4E8E-821B-344043FF373A

P407

Q28477900-A0BF7C3C-D566-4ED0-B99F-D3681CF612B7

P433

Q28477900-5B167E28-56DA-41CE-9EFE-EF2CAA880ED0

P478

Q28477900-C5ACC2A5-2B3A-4D50-8F9A-53E6A27D59DB

P50

Q28477900-1AE2D946-C2F1-4F2E-B818-4B647D667A58

Q28477900-206CC9EB-BA79-4528-BEAD-60BCE2E76035

Q28477900-3E66E6E1-AFAF-4CF1-847E-8BBD27A78274

Q28477900-BCD41F8B-B102-42EF-A3B8-EDCE49ECDB58

Q28477900-CD1CF057-4A72-4C0D-9100-B383024E70F1

P577

Q28477900-28353265-01E2-4716-A25F-51DC91135054

P5875

Q28477900-57407ABA-558C-4D0A-8D23-0FBEF4EAE570

P698

Q28477900-ABE539E7-3133-4408-BEF8-DEF4A371BF56

P921

Q28477900-03576183-AE3A-49AE-8E72-3949AA4C688E

P932

Q28477900-BEE8CEF5-D2D0-44DD-ACCE-AF515FDC412C

P3181

P356

JOURNAL.PPAT.1002359

P1433

P1476

Evolution of multidrug resista ...... two component regulator WalKR

@en

P2093

Christopher R E McEvoy

http://www.w3.org/2001/XMLSchema#string

David L Allen

http://www.w3.org/2001/XMLSchema#string

Jan Bell

http://www.w3.org/2001/XMLSchema#string

Jessica L Porter

http://www.w3.org/2001/XMLSchema#string

John K Davies

http://www.w3.org/2001/XMLSchema#string

Kyra Chua

http://www.w3.org/2001/XMLSchema#string

Paul F Harrison

http://www.w3.org/2001/XMLSchema#string

Vicki Bennett-Wood

http://www.w3.org/2001/XMLSchema#string

Wei Gao

http://www.w3.org/2001/XMLSchema#string

P2860

The COG database: an updated version includes eukaryotes

SHRiMP: accurate mapping of short color-space reads

Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications

BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data.

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus

Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation

Characterisation of Australian MRSA strains ST75- and ST883-MRSA-IV and analysis of their accessory gene regulator locus

Autoinduction and signal transduction in the regulation of staphylococcal virulence

An integrated semiconductor device enabling non-optical genome sequencing

P304

e1002359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

37854

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PPAT.1002359

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Timothy Stinear

Torsten Seemann

Geoffrey Coombs

Benjamin P. Howden

Roy M Robins-Browne

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51816933

http://www.w3.org/2001/XMLSchema#string

P698

22102812

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

3213104

http://www.w3.org/2001/XMLSchema#string